Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Pharma Firm, Director Under ED Lens Over Alleged Rs 60 Crore PNB Fraud

ED raid at Chandigarh based pharma company, promoters in money laundering probe

Ruchika Sharma28 Oct 2023 8:30 AM IST

According to CBI officials, the private company was engaged in manufacturing drugs and allegedly defrauded the consortium of banks through criminal...

Cipla reports bigger-than-expected rise in Q2 profit

Ruchika Sharma28 Oct 2023 6:15 AM IST

Higher market share in cancer drugs Revlimid and Lanreotide and lower price erosion have helped Cipla's sales in the North American market, analysts...

USFDA nod to JnJ Tremfya for Crohns disease

JnJ faces 18 talc cancer trials, prompting it again to consider bankruptcy

Ruchika Sharma27 Oct 2023 5:25 PM IST

Johnson & Johnson faces at least 18 jury trials over the next year tied to claims of tainted talc in its iconic baby powder, prompting the company...

Dr Reddys Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, Europe

Celevida Wellness: Dr Reddys launches Direct-to-consumer e-commerce website for diabetes nutrition

Ruchika Sharma27 Oct 2023 12:58 PM IST

Hyderabad: Dr Reddy’s Laboratories Ltd., a global pharmaceutical company, has announced the launch of its first direct-to-consumer (D2C)...

Eli Lilly Omvoh gets USFDA okay for Ulcerative Colitis in adults

Ruchika Sharma27 Oct 2023 12:19 PM IST

Omvoh will be available in the United States in the coming weeks.

Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE Mark

Roche bags USFDA nod for Vabysmo to treat retinal vein occlusion

Ruchika Sharma27 Oct 2023 11:32 AM IST

"Vabysmo is a new treatment option for RVO that can help people preserve and improve their vision, with the added benefit of retinal drying," said...

No observations: USFDA inspection at Cipla arm InvaGen New York plant concludes

Ruchika Sharma27 Oct 2023 7:30 AM IST

Mumbai: Drugmaker Cipla has announced that the United States Food and Drug Administration (USFDA) has concluded inspection with zero Form 483...

Mumbai: Pharma office under Maha GST Dept inspection

Ruchika Sharma27 Oct 2023 5:45 AM IST

Mumbai: The Maharashtra Goods and Services Tax Department has begun an inspection at Mumbai-based J.B. Chemicals & Pharmaceuticals Limited's...

HIV-1 injectable treatment: GSK's ViiV Healthcare gets Chinese nod for Vocabria used in combination with Rekambys

Ruchika Sharma26 Oct 2023 4:21 PM IST

London: GSK plc has announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as...

UP STF Set to Name Pharma Firms in Multi-Crore Codeine Syrup Scam

Gambia trial opens over children death who consumed Maiden Pharma cough syrup

Ruchika Sharma26 Oct 2023 4:14 PM IST

Banjul: A trial opened Tuesday in The Gambia's capital Banjul over the deaths of small children who took a cough syrup made by the India-based Maiden...

Failed Drugs, Loss of Patent: Japanese drugmaker Takeda slashes full-year profit forecast by 36 percent

Ruchika Sharma26 Oct 2023 3:21 PM IST

Tokyo: Japan's biggest drugmaker Takeda Pharmaceutical has slashed its full-year profit forecast by 36% as it contends with disappointments in...

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck discontinues some cancer drug development with Sichuan Kelun Pharma

Ruchika Sharma26 Oct 2023 2:38 PM IST

Shanghai: Chinese drugmaker Sichuan Kelun Pharmaceutical Co has said that Merck & Co Inc was abandoning the joint development of...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok